D&B Finance Analytics
AI-driven solutions for credit-to-cash powered by Dun & Bradstreet’s global data and analytics. D&B Finance Analytics offers AI-driven solutions backed by the Dun & Bradstreet Data Cloud. D&B Finance Analytics is a flexible, easy-to-use tool that helps finance teams reduce costs, improve customer service, and manage risk. Manage credit and receivables risks to minimize bad debts, reduce DSO and improve cash flow. Automate manual decisioning and monitoring, customer communication, and matching. Offer your customers an online credit application as well as a payment portal. D&B Finance Analytics consists of two platforms: D&B Credit Intelligence and D&B®, Receivables Intelligence. Together, they provide powerful insights and technologies to help you accelerate your success throughout all your credit-to cash processes. You can quickly gain visibility into credit risks, onboard customers, and set the right terms.
Learn more
Fraud.net
Don't let fraud erode your bottom line, damage your reputation, or stall your growth. FraudNet's AI-driven platform empowers enterprises to stay ahead of threats, streamline compliance, and manage risk at scale—all in real-time. While fraudsters evolve tactics, our platform detects tomorrow's threats, delivering risk assessments through insights from billions of analyzed transactions.
Imagine transforming your fraud prevention with a single, robust platform: comprehensive screening for smoother onboarding and reduced risk exposure, continuous monitoring to proactively identify and block new threats, and precision fraud detection across channels and payment types with real-time, AI-powered risk scoring. Our proprietary machine learning models continuously learn and improve, identifying patterns invisible to traditional systems. Paired with our Data Hub of dozens of third-party data integrations, you'll gain unprecedented fraud and risk protection while slashing false positives and eliminating operational inefficiencies.
The impact is undeniable. Leading payment companies, financial institutions, innovative fintechs, and commerce brands trust our AI-powered solutions worldwide, and they're seeing dramatic results: 80% reduction in fraud losses and 97% fewer false positives. With our flexible no-code/low-code architecture, you can scale effortlessly as you grow.
Why settle for outdated fraud and risk management systems when you could be building resilience for future opportunities? See the Fraud.Net difference for yourself. Request your personalized demo today and discover how we can help you strengthen your business against threats while empowering growth.
Learn more
SafetyEasy
For nearly 20 years, AB Cube has been a trusted partner in safety management, delivering not just innovative technology, but transparent, compliant solutions designed to scale with your needs and grow alongside your organization.
Learn more
IQVIA Vigilance Platform
The IQVIA Vigilance Platform represents a holistic solution designed to streamline safety and pharmacovigilance tasks, enhancing speed, precision, and overall efficiency. Operating within a secure Software-as-a-Service (SaaS) environment and leveraging advanced proprietary technologies such as artificial intelligence, machine learning, and natural language processing, the Vigilance Platform provides valuable insights that enhance compliance, ensure product safety, and contribute significantly to the product development lifecycle. It comprehensively addresses every facet of pharmacovigilance, managing cases from initial patient reports through processing and submission to regulatory authorities, encompassing all types of cases. With its user-friendly interface, the IQVIA Vigilance Platform is accessible for affiliates, case processing teams, and those involved in signal detection. By adopting a transformative methodology in pharmacovigilance, it bolsters compliance, allowing organizations to concentrate on the rapid delivery of safer and more effective pharmaceuticals and medical devices. This innovative platform not only meets current industry needs but also anticipates future requirements in the evolving landscape of drug safety and efficacy.
Learn more